cialis
Check on tripsit
Tadalafil
Check on isomerdesign
Tadalafil
Check on pubchem
Tadalafil
Check on drugmap
Data
InChI: InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3
Synonyms: 171596-29-5,NC00223,596T295,BRD-K93645900-001-04-8,AMY10321,(6R,12aR) 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino [1',2':1,6] pyrido[3,4-b]indole-1,4-dione,HY-90009A,CS-1414,(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11,13,15-tetraene-4,7-dione,TADALAFIL [EP MONOGRAPH],Zalutia (TN),BT164435,6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione,A23556,(6R,12 aR)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione,PYRAZINO(1',2':1,6)PYRIDO(3,4-B)INDOLE-1,4-DIONE, 6-(1,3-BENZODIOXOL-5-YL)-2,3,6,7,12,12A-HEXAHYDRO-2-METHYL-, (6R-12AR)-,TADALAFIL [JAN],TADALAFIL [USP MONOGRAPH],ZINC3993855,CHEMBL779,NCGC00168781-01,(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1,2:1,6]pyrido[3,4-b]indole-1,4-dione, IC 351,Tadanafil,NSC 750236,UNII-742SXX0ICT,LY-450190,TADALAFIL [WHO-DD],MFCD07771966,(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione,Tox21_112642,GF-196960,Tadalafila,(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione,Tadalafil (JAN/USP/INN),GF196960,BDBM14777, KS-1117,HSDB 7303,(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, Cialis (TN),Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-, Ic351, Cialis,IC 351,TADALAFIL; CIALIS,6-BENZO[1,3]DIOXOL-5-YL-2-METHYL-2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE,SMR000466321, Lilly brand of tadalafil,Tadalafil [USAN],Tox21_112642_1,NSC750236,Taldalafil,NSC 759172,Cialis,(-)-Tadalafil (6R),(6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione,(2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11(16),12,14-tetraene-4,7-dione,IC-351,1242099-07-5,TADALAFIL [EMA EPAR],TADALAFIL [MI],Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R-trans)-, GF 196960,(-)-Tadalafil (6R ,12aS) diastereomer,Tadalafil 100 microg/mL in Acetonitrile,(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione,CCG-100973, Tadalafil [USAN],ADCIRCA,HMS3884G19,TILDENAFIL,(6R,12aR) 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione,CHEBI:71940,SR-05000001940-1,GTPL7299,HMS2235L21,D02008,Pyrazino[1',6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12ahexahydro-2-methyl-, (6R,12aR)-,(2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11,13,15-tetraene-4,7-dione,NSC759172,DSSTox_GSID_46786,Tadalafil solution,KS-1117,ENTADFI COMPONENT TADALAFIL,Tadalafil(Cialis),NCGC00263909-02,171488-03-2,AB00639969_09,TADALAFIL [MART.], Cialis, GF 196960, IC 351, ICOS 351, Tadalafil,Tadalafil Lilly,DSSTox_CID_26786, (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione,SCHEMBL33333,EX-A2644,MLS000759426,TADALAFIL [ORANGE BOOK],TADALAFIL [INN],GF 196960,Q424156,TADALAFIL COMPONENT OF ENTADFI,ICOS 351,AKOS015892559,Tadalafil (Cialis),DTXSID9046786, (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione,MLS001424132,MLS006010126,(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione,Tadalafil specified impurity A,(6R,3,6,7,12,12a-Hexahydro-2-methyl-6-[3,4-(methylenedioxy)phenyl]pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione,LY450190,NSC-759172, IC-351,Tadalafil solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Tadalafil (JAN/USAN/INN),AB42193,DB00820,1,3-benzodioxol-5-yl(methyl)[?]dione,MLS001165782,AB00639969-08,Adcirca (TN),TADALAFIL [VANDF],Z1501485354,Tadalafil,(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1,2,1,6]pyrido[3,4-b]indole-1,4-dione,SR-05000001940,AB00639969_10, Tadanafil,Tadalafilo,(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino- (1',2':1,6)pyrido(3,4-b)indole-1,4-dione,Tadalafil mylan,742SXX0ICT,(6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione,Tadalafil [USAN:INN:BAN],1xoz,SW197603-2, ICOS 351,CAS-171596-29-5, (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione,HMS2051N17,Trans-tadalafil, GF-196960,Pharmakon1600-01505639,Tadalafil 1.0 mg/ml in Acetonitrile,Tadalafil (6R ,12aS)- Lilly,AR-270/43507798,DSSTox_RID_81904,MLS001195644, Acdirca,Tadalafil- Bio-X,Ic351,Cialis, Tadalafil,(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione,s1512,NSC-750236,rel-(6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione,TADALAFIL [USP-RS],Cialis (TN),TADALAFIL [HSDB]
Estimated data
Solubility: -4.934 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: No (prediction using frontiersin.org)
Addictivity Prediction: 24.7% (prediction based on www.mdpi.com)
